Vijay Dhaka has close to 20 years of healthcare experience focused on identifying, protecting, licensing, investing in, developing, and implementing innovative medical technologies. Most recently Vijay was the Assistant Director of the Coulter Translational Partnership at USC, a medical innovation gap funding program that identifies promising technologies that meet unmet clinical needs, provides non-dilutive funding to de-risk selected technologies by gathering commercially relevant clinical data, managing intellectual property, and negotiating licenses. Vijay began his career spending nearly a decade in R&D at venture backed class II and III medical device companies: VNUS Medical Technologies (IPO; acquired by Covidien), Adiana Inc. (acquired by Cytyc, currently Hologic), and Oratec Interventions (acquired by Smith+Nephew). Interested in expanding his skills beyond engineering Vijay pursued his MBA, and subsequently joined consulting firm McKinsey & Co with a focus on healthcare. Engagements included private equity due diligence, corporate strategy, and market strategy. After a detour into strategy and business development at ESPN, Vijay worked on developing clinical care programs at Apria Healthcare including digital health, remote patient monitoring, and patient compliance. Vijay has been a frequent guest lecturer at USC on medical device commercialization, intellectual property, and licensing negotiations. Vijay has a MBA from MIT Sloan School of Management and a BS in BioEngineering from the University of California, San Diego.